Skip to content

SRZN

Surrozen, Inc./DE

NASDAQ · Healthcare · Biotechnology · US

$16.55
−2.30%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 6, 2026
EPS estimate
-$1.10
Revenue estimate
$467.3K

Latest reported

Last report date
Aug 6, 2026
EPS actual
-$0.41
EPS estimate
-$1.29
Revenue actual
$5.0M
Revenue estimate
$467.3K

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
6
EPS in line (12Q)
1
Avg surprise (4Q)
-202.9%
Revenue beats (12Q)
2

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$44
PT range
$44 – $44
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026-$1.29-$0.41Beat 68.22%$5.0M
May 6, 2026-$1.39-$4.63Miss -233.09%$5.0M
Mar 23, 2026-$1.41-$7.59Miss -438.30%$528.0K
Nov 7, 2025-$1.17-$3.61Miss -208.55%$983.0K
Aug 8, 2025-$1.23-$1.14Beat 7.32%$983.0K
May 9, 2025-$1.09-$3.13Miss -187.16%$983.0K
Mar 31, 2025-$2.54-$9.10Miss -258.27%$655.0K
May 8, 2024-$4.25-$4.24Beat 0.24%
May 10, 2023-$5.10-$7.20Miss -41.18%
Mar 22, 2023-$6.75-$0.45Beat 93.33%$12.5M
Nov 14, 2022-$6.45-$5.70Beat 11.63%
Aug 11, 2022-$6.90-$6.00Beat 13.04%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026